Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile
Ishwaria Subbiah, MD MS FASCO

@ishwariamd

Exec Director for #heathequity #clinicaltrials access, #supportivecare and professional #wellbeing at @TheUSONetwork and #SCRI | Onc & #PalliativeCare physician

ID: 175735226

linkhttps://www.linkedin.com/in/ishwariamd calendar_today07-08-2010 13:07:20

10,10K Tweet

9,9K Followers

2,2K Following

Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

Superb discussion within our Cancer and Aging Research Group (CARG) #GeriOnc core call on dissemination of evidence-based care of older adults with #cancer. Check out our recently released ASCO Guideline Update -- honored to be a small part of this effort published in Journal of Clinical Oncology on the Practical Assessment and

Superb discussion within our <a href="/myCARG/">Cancer and Aging Research Group (CARG) #GeriOnc</a> core call on dissemination of evidence-based care of older adults with #cancer. Check out our recently released ASCO Guideline Update -- honored to be a small part of this effort published in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> on the Practical Assessment and
Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

How it started🤩 How it’s going👎 The #Paris2024 #OpeningCeremony Edition 🔹Steady unrelenting rains. Attendees soaked to the bone, taking refuge under their nearest bridge (📷 me under the Pont Neuf). Soaked athletes sailing by without announcement. ‼️No sign of a weather

How it started🤩     How it’s going👎 
The #Paris2024 #OpeningCeremony Edition
🔹Steady unrelenting rains. Attendees soaked to the bone, taking refuge under their nearest bridge (📷 me under the Pont Neuf). Soaked athletes sailing by without announcement.
‼️No sign of a weather
FDA Oncology (@fdaoncology) 's Twitter Profile Photo

ASCO is now accepting applications for the October 2024 Hybrid FDA-ASCO Fellows’ Day Workshop through August 5: asco.smapply.org/prog/OctoberFe… Photo: Spring 2024 FDA-ASCO Fellows Day #OCEProjectSocrates

ASCO is now accepting applications for the October 2024 Hybrid FDA-<a href="/ASCO/">ASCO</a> Fellows’ Day Workshop through August 5: asco.smapply.org/prog/OctoberFe… 

Photo: Spring 2024 FDA-ASCO Fellows Day
#OCEProjectSocrates
Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

🔸That's a wrap! July 2024 was defined by impactful cross-stakeholder dialogue that started on day 1 (while at Yosemite National Park, no less). 📷Privileged to present at the July 1 Rounds of the U.S. FDA Oncology Center of Excellence (OCE) FDA Oncology on expanding #clinicaltrial access

🔸That's a wrap! July 2024 was defined by impactful cross-stakeholder dialogue that started on day 1 (while at <a href="/YosemiteNPS/">Yosemite National Park</a>, no less).
📷Privileged to present at the July 1 Rounds of the <a href="/US_FDA/">U.S. FDA</a> Oncology Center of Excellence (OCE) <a href="/FDAOncology/">FDA Oncology</a> on expanding #clinicaltrial access
Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

🔸Spotted several ASCO IDEA recipients in this group of leaders committed to ending cancer as we know it through global collaboration!🚨IDEA applications are open now🚨— deadline Sept 30, 2024. 🔗👇 🔸Cheers to Robin Zon Julie Gralow Vanessa Eaton Mandy Davis Aitken and ASCO for

chadi nabhan MD, MBA, FACP (@chadinabhan) 's Twitter Profile Photo

Can we fight burnout? Can we improve wellbeing of physicians? ⁦Ishwaria Subbiah, MD MS FASCO⁩ of ⁦Sarah Cannon Docs⁩ is working tirelessly 2 make it happen. We discussed on #HealthcareUnfiltered her initiatives & what can be done. Clip below and full link here: podcasts.apple.com/us/podcast/hea…

Freddy E Escorcia (@freddyeescorcia elsewhere) (@freddyeescorcia) 's Twitter Profile Photo

Excellent points toward addressing the addressable to decrease ok physician burnout by Ishwaria Subbiah, MD MS FASCO chadi nabhan MD, MBA, FACP Chip away at unnecessary clicks and non-medical tasks Single click attestations versus weeks worth of modules …otherwise stew in a culture of learned helplessness

Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

The Sarah Cannon Docs commitment to advance cancer research runs deep! 🔹Education of physicians and multidisciplinary team members is critical to sustained success of the mid- and long-term vision to broaden access to #clinicaltrials. 🔹Today’s highlight - meeting with our

The <a href="/SarahCannonDocs/">Sarah Cannon Docs</a> commitment to advance cancer research runs deep! 
🔹Education of physicians and multidisciplinary team members is critical to sustained success of the mid- and long-term vision to broaden access to #clinicaltrials.
🔹Today’s highlight - meeting with our
Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

🔈Healthcare professional #wellbeing and #burnout are *actionable* in *meaningful* and *measurable* ways, but only if organizations shape their approach appropriately! Otherwise, the risk for boiling the ocean is high. 🔸 Check out my episode on #HealthcareUnfiltered podcast with

🔈Healthcare professional #wellbeing and #burnout are *actionable* in *meaningful* and *measurable* ways, but only if organizations shape their approach appropriately! Otherwise, the risk for boiling the ocean is high.
🔸 Check out my episode on #HealthcareUnfiltered podcast with
Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

🔹Starting the day with an U.S. FDA FDA Oncology approval — #lazertinib + #amivantamab-vmjw for non-small #lungcancer! 🔹Perfect time to get ready with the #supportivecare symptom management plan for our patients! 🔹 The most common adverse reactions (≥20%) were rash, nail

Bernardo Haddock Lobo Goulart (@lobo_goulart) 's Twitter Profile Photo

Another option for patients with NSCLC and sensitizing EGFR mutations FDA Oncology Keep an eye on DVTs/PEs (36%) and don’t forget the recs for prophylactic anticoagulantion!

Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

🚨🥁 Hot off the press 👉 Presenting to the world a future framework for Tissue agnostic drug development - Special article published Annals of Oncology –an X 'torial for this major milestone in #precisionMedicine ✅1/n - “The ESMO Tumour-Agnostic Classifier and Screener

🚨🥁 Hot off the press 👉 Presenting to the world a future framework for Tissue agnostic drug development - Special article published <a href="/Annals_Oncology/">Annals of Oncology</a> 
 –an <a href="/X/">X</a> 'torial for this major milestone in #precisionMedicine
✅1/n - “The ESMO Tumour-Agnostic Classifier and Screener
Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

#Advocacy moves mountains! 🔸 Celebrating Women's #EqualityDay today, marking the 104th anniversary of the 19th Amendment, granting many women the right to vote. Note: for many women of color, that right to vote came with the Voting Rights Act of 1965. archives.gov/milestone-docu…

#Advocacy moves mountains! 🔸 Celebrating Women's #EqualityDay today, marking the 104th anniversary of the 19th Amendment, granting many women the right to vote. Note: for many women of color, that right to vote came with the Voting Rights Act of 1965. archives.gov/milestone-docu…
Fernando Diaz, MD (@fernandodiazmd1) 's Twitter Profile Photo

Excellent and timely piece Cristiane D Bergerot, Mazie Tsang, MD, MAS, MS, and Ramy Sedhom, MD. ✅ 💻Telehealth has been critical to many of my older adult patients and those living in rural parts of the state. Unfortunately, the flexible provisions associated with telehealth given after the pandemic

Excellent and timely piece <a href="/crisbergerot/">Cristiane D Bergerot</a>, <a href="/MazieTsangMD/">Mazie Tsang, MD, MAS, MS</a>, and <a href="/ramsedhom/">Ramy Sedhom, MD</a>. ✅

💻Telehealth has been critical to many of my older adult patients and those living in rural parts of the state. Unfortunately, the flexible provisions associated with telehealth given after the pandemic
Ishwaria Subbiah, MD MS FASCO (@ishwariamd) 's Twitter Profile Photo

I contacted my lawmakers about protecting patients' timely access to #cancer care. Join me! #ASCOAdvocacy 🔗asco.quorum.us/campaign/47459 ASCO has endorsed the Improving Seniors’ Timely Access to Care Act (H.R. 8702/S.4532), bipartisan legislation to streamline the prior